Strides Pharma Science Share Price

Strides Pharma Science Share Price

NSE: STAR
|
Pharmaceuticals
|
S Cap
₹ 1,182.10
-₹13.60 (-1.14%)
1D
Last updated 10 Sep, 2026, 09:29 IST

Strides Pharma Science Share Price Today

As of 10 Sep 2026, Strides Pharma Science share price is ₹1,182.10. The stock opened at ₹1,189.00, compared to its previous close of ₹1,195.70. During today's trading session, Strides Pharma Science share price moved in the range of ₹1,159.70 to ₹1,192.20, with an average price of ₹1,175.95 for the day. Looking at its last 52-week, the stock has touched a low of ₹768.65 and a high of ₹1,231.00. On the performance front, Strides Pharma Science share price has increased by 38.02% over the last six months and is up 36.15% on a year-on-year basis.

₹1,159.70
1.14% down today
₹1,192.20
1D LOW
1D HIGH

Strides Pharma Science Returns Calculator

Circuit
L
H
₹956.60
₹1,434.80
52-week
L
H
₹768.65
₹1,231.00

About Strides Pharma Science

Strides Pharma Science Share Price
ISIN
INE939A01011
Sector Market Cap
₹ 10,913.71 Cr

Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.

Strides Pharma Science Financial Highlights

  • Revenue: Strides Pharma Science reported revenue of ₹5,009.39 crore in FY26 vs ₹4,624.06 crore in FY25. It showed an increase of 8.33% on a yearly basis.
  • Operating Profit: Strides Pharma Science reported an operating profit of ₹668.69 crore in FY26 vs ₹486.92 crore in FY25. It showed an increase of 37.33% on a year-on-year basis.
  • Net Profit: Strides Pharma Science reported a net profit of ₹574.52 crore in FY26 vs ₹3,597.51 crore in FY25. It showed a decrease of 84.03% on a yearly basis.

Strides Pharma Science Quarterly Result Highlights

  • Strides Pharma Science reported revenue of ₹1,270.30 crore in Jun 2026, compared with ₹1,331.60 crore in Mar 2026, representing a decrease of 4.60% on a quarter-on-quarter (QoQ) basis.
  • Strides Pharma Science reported an operating profit of ₹199.62 crore in Jun 2026, compared with ₹148.05 crore in Mar 2026, representing an increase of 34.83% on a quarter-on-quarter (QoQ) basis.
  • Strides Pharma Science reported a profit of ₹165.49 crore in Jun 2026, compared with ₹129.28 crore in Mar 2026, reflecting an increase of 28.01% on a QoQ basis.
  • The earnings per share (EPS) of Strides Pharma Science stood at ₹60.34 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
27.91%
FII
28.39%
Other DII
6.68%
Retail and other
28.28%
Mutual funds
8.73%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 202528.51%
Dec 202529.52%
Mar 202628.68%
Jun 202628.39%
Mkt Cap Cr
11,044.60
P/E
17.41
P/B
3.55
ROE
17.90%
D/E
0.36
ROCE
17.30%
Div. Yield
0.42%
EPS(TTM)
19.92
Turnover
0.42
EV/EBITDA
11.07
Net Margin
3.37%
Op. Margin
14.11%
ROA
9.16%
Quick Ratio
0.97
Curr. Ratio
2.80
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Strides Pharma outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Strides Pharma appears overvalued compared to its peers
Step 4 of 5
Earnings
Good
Strides Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,51,339.0037.005.3613.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,54,068.0086.0715.0215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,87,594.0087.0122.3125.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,12,618.0024.524.1518.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,804.0032.933.2111.27%0.0014.95%423.360.95%0.4543.52
Laurus Labs1,05,118.0095.8019.7116.77%0.4016.14%97.200.10%0.6713.72
Aurobindo Pharma97,008.7026.212.579.25%0.1911.76%394.820.24%0.3841.58
Lupin95,660.0017.234.2623.76%0.0424.88%659.000.86%0.57129.18
Dr. Reddy's Laboratories96,113.4029.972.5111.07%0.1812.54%377.950.70%0.4138.68
Mankind Pharma93,596.0045.275.7411.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Strides Pharma Science Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹4,858.68₹4,565.34₹3,890.13₹3,688.39
Other Income₹150.71₹58.72₹39.70₹90.33
Total Revenue₹5,009.40₹4,624.06₹3,929.83₹3,778.72
Total Expenses₹4,314.34₹4,203.63₹3,801.61₹3,762.60
Profit Before Tax₹668.69₹486.92-₹114.79-₹286.20
Tax₹94.17₹77.52₹29.11-₹55.30
Profit After Tax₹574.52₹409.41-₹143.90-₹230.90
EPS - Basic₹60.34₹390.55-₹7.76-₹22.49
EPS - Diluted₹60.34₹390.50-₹7.76-₹22.49

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹668.69₹3,675.03-₹62.72-₹267.63
Income before WC changes₹874.08₹790.91₹755.55₹414.56
Change in Assets-₹411.17-₹278.51₹69.79-₹355.52
Change in Liabilities₹310.72₹104.93-₹148.53-₹102.28
Change in WC-₹100.45-₹173.58-₹78.73-₹457.80
Cash flow from Operations₹702.52₹684.37₹701.07₹44.41
Cash flow from Investing-₹173.04-₹89.69-₹150.25₹302.47
Cash flow from Financing-₹453.41-₹642.58-₹693.32-₹213.92
Total Cash Flow₹76.07-₹47.90-₹142.51₹132.96
Cash (Start of the year)₹112.56₹161.02₹303.50₹170.73
Cash (End of the year)₹188.70₹112.56₹161.02₹303.50

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹3,313.89₹2,949.81₹2,870.76₹3,395.06
Current Assets₹3,613.34₹3,098.91₹2,969.00₹3,243.36
Total Assets₹6,927.23₹6,048.73₹5,839.76₹6,638.42
Current Liabilities₹2,895.49₹2,591.52₹2,879.26₹2,990.20
Net Current Asset₹717.85₹507.39₹89.74₹253.16
Non-Current Liabilities₹882.40₹870.74₹888.79₹1,475.34
Equity Capital₹3,149.34₹2,586.46₹2,071.71₹2,172.88
Total Equity & Liabilities₹6,927.23₹6,048.73₹5,839.76₹6,638.42

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,180.14₹2,139.42₹1,866.12₹1,854.50
Other Income₹123.06₹46.19₹58.71₹84.07
Total Revenue₹2,303.20₹2,185.61₹1,924.83₹1,938.56
Total Expenses₹2,100.10₹2,107.50₹1,942.40₹1,988.32
Profit Before Tax₹203.10₹78.08-₹22.93-₹64.76
Tax₹19.47₹18.93₹1.34-₹69.44
Profit After Tax₹183.64₹59.16-₹24.28₹4.68
EPS - Basic₹19.92₹313.68₹4.90₹0.52
EPS - Diluted₹19.92₹313.65₹4.89₹0.52

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹203.10₹2,905.14₹40.99-₹64.76
Income before WC changes₹248.66₹287.25₹291.89₹108.11
Change in Assets-₹166.78₹34.32-₹244.22₹20.63
Change in Liabilities₹197.26-₹22.61-₹115.39₹13.18
Change in WC₹30.48₹11.72-₹359.60₹33.81
Cash flow from Operations₹277.85₹421.48-₹14.01₹241.74
Cash flow from Investing-₹69.07-₹137.59-₹69.57-₹182.58
Cash flow from Financing-₹198.93-₹370.32₹93.34₹10.82
Total Cash Flow₹9.84-₹86.42₹9.77₹69.98
Cash (Start of the year)₹6.33₹92.75₹82.11₹12.12
Cash (End of the year)₹16.17₹6.33₹92.75₹82.11

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹3,022.13₹2,885.44₹3,490.70₹3,493.34
Current Assets₹2,373.59₹2,145.50₹2,411.18₹2,126.40
Total Assets₹5,395.72₹5,030.95₹5,901.87₹5,619.74
Current Liabilities₹1,840.07₹1,629.61₹2,085.14₹1,796.83
Net Current Asset₹533.52₹515.89₹326.04₹329.58
Non-Current Liabilities₹272.13₹208.60₹289.13₹367.86
Equity Capital₹3,283.52₹3,192.74₹3,527.60₹3,455.05
Total Equity & Liabilities₹5,395.72₹5,030.95₹5,901.87₹5,619.74
* All values are in INR Crore
Qty
Bid
28
1182.2
4
1182.1
17
1182
32
1181.9
40
1181.8
Ask
Qty
1182.8
10
1182.9
42
1183
16
1183.1
1
1183.2
3
Bid Total: 121
Ask Total: 72
Buy orders: 63%
Sell orders: 37%
Bearish
5
Neutral
1
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
79.35
Bullish
ATR (14)
38.54
Neutral
STOCH(9,6)
90.93
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
51.54
Bearish
UO(9)
70.9
Bearish
ROC(12)
20.34
Bullish
WillR(14)
-8.64
Bearish
Period
Simple value
Exponential vaue
5D
1135.02
1145.92
10D
1077.5
1099.43
20D
1028.4
1060.72
50D
1041.5
1044.92
100D
1066.73
1034.12
Volume trend — traded volume by day
10 Sep0L
9 Sep3L
8 Sep4L
7 Sep26L
4 Sep2L
3 Sep1L
Average6L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Strides Pharma Science Share Price
Strides Pharma Science
Pharmaceuticals
Add Stock
Add Another

Strides Pharma Science Share Price FAQs

Strides Pharma Science share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837